查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗凝血剂市场：按药物类别、应用、地区划分——规模、份额、展望、机会分析，2022-2028 年
市场调查报告书
商品编码
1213864

抗凝血剂市场：按药物类别、应用、地区划分——规模、份额、展望、机会分析，2022-2028 年

Anticoagulant Market, By Drug Class, By Application, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3个工作天内

价格
简介目录

抗凝剂是一种防止血液凝块的药物。 通常称为血液稀释剂。 它用于发生血栓的高风险人群，以减少出现严重症状（如中风或心脏病发作）的机率。 抗凝剂通常用于预防和治疗心血管疾病 (CVD)。

市场动态

全球慢性病流行、抗凝剂需求增加、新型抗凝剂开发重点以及老年人口增加预计将成为推动全球抗凝剂市场增长的主要因素。我来了。

例如，2022 年 6 月，Apotex 宣布推出 APO-Apixaban 片剂，这是加拿大首个 Eliquis 的仿製药替代品。 阿□沙班是一种口服抗凝剂，用于预防和治疗有害血栓。

此外，2021 年 6 月，美国食品药品监督管理局 (FDA) 批准了 pradaxa（达比加群酯）口服微丸用于治疗 3 个月至 12 岁儿童的静脉血栓栓塞症。 FDA 还批准了 pradaxa 口服微丸用于预防 3 个月至 12 岁以下已完成初始静脉血栓栓塞治疗的患者的复发性血栓。

这项研究的主要特点

  • 本报告对全球抗凝剂市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR%) 的增长情况。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 全球抗凝剂市场主要参与者的概况基于以下参数，包括公司亮点、产品组合、主要亮点、绩效和策略。
  • 参与这项研究的主要公司包括辉瑞公司、赛诺菲公司、雷迪博士实验室、Aspen Holdings、Abbott Laboratories、Leo Pharma、Alexion Pharmaceuticals Inc.、拜耳公司、强生公司、百时美施贵宝公司、Daiichi Sankyo Company 和 Boehringer Ingelheim Pharmaceuticals Inc. 等。
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 《全球抗凝血剂市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球抗凝剂市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按药物类别
    • 市场概况：按应用分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 全球慢性病发病率上升
    • 严格的政府法规
    • 对开发新型抗凝血剂的兴趣日益浓厚
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/批准
  • 害虫分析
  • 对 PORTER 的分析
  • 合併/收购场景

第 4 章全球抗凝剂市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学
  • 供应方和需求方分析
  • 经济影响

第 5 章全球抗凝剂市场：按药物类别，2017-2028

  • 新型口服抗凝剂 (NOAC)
  • 肝素和低分子肝素 (LMWH)
  • 维生素 K 拮抗剂

第 6 章全球抗凝剂市场：按应用，2017-2028

  • 心房颤动/心肌梗塞（心脏病发作）
  • 深静脉血栓形成 (DVT)
  • 肺栓塞
  • 其他用途

第 7 章全球抗凝剂市场：按地区划分，2017-2028

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地方

第八章竞争格局

  • Pfizer Inc.
  • Sanofi SA
  • Dr. Reddy's Laboratories
  • Aspen Holdings
  • Abbott Laboratories
  • Leo Pharma AS
  • Alexion Pharmaceuticals Inc.
  • Bayer AG
  • Johnson & Johnson
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Boehringer Ingelheim Pharmaceuticals Inc.

第 9 章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5486

Anticoagulants are a class of drugs that help prevent blood clots. They are commonly called blood thinners. They're given to people at a high risk of getting clots, to reduce the chances of developing serious conditions such as strokes and heart attack. Anticoagulants are commonly used to prevent and treat cardiovascular diseases (CVDs).

Market Dynamics:

Growing prevalence of chronic disease, rise in demand for anticoagulants, increase in focus on the development of novel anticoagulants, and growing geriatric population across the globe are major factors expected to drive growth of the global anticoagulant market.

For instance, in June 2022, Apotex Inc. announced the launch of APO-Apixaban tablets, Canada's first generic alternative to Eliquis. Apixaban is an oral anticoagulant indicated for the prevention and treatment of harmful blood clots.

Moreover, in June 2021, the Food and Drug Administration (FDA) approved Pradaxa (dabigatran etexilate) oral pellets to treat children three months to 12 years old with venous thromboembolism. FDA also approved Pradaxa oral pellets to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism.

Key features of the study:

  • This report provides in-depth analysis of the global anticoagulant market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global anticoagulant market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Sanofi SA, Dr. Reddy's Laboratories, Aspen Holdings, Abbott Laboratories, Leo Pharma, Alexion Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Bristol-Myers Squibb Company, Daiichi Sankyo Company, and Boehringer Ingelheim Pharmaceuticals Inc., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global anticoagulant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anticoagulant market.

Detailed Segmentation:

  • Global Anticoagulant Market, By Drug Class:
    • Novel Oral Anticoagulants (NOACs)
    • Heparin and Low-molecular- weight Heparin(LMWH)
    • Vitamin K Antagonist
  • Global Anticoagulant Market, By Application:
    • Atrial Fibrillation/Myocardial Infarction (Heart Attack)
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism
    • Other Applications
  • Global Anticoagulant Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Pfizer Inc.
    • Sanofi SA
    • Dr. Reddy's Laboratories
    • Aspen Holdings
    • Abbott Laboratories
    • Leo Pharma AS
    • Alexion Pharmaceuticals Inc.
    • Bayer AG
    • Johnson & Johnson
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company
    • Boehringer Ingelheim Pharmaceuticals Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Application
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of chronic diseases across the globe
    • Stringent government regulations
    • Rise in focus on the development of novel anticoagulants
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Anticoagulant Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Anticoagulant Market, By Drug Class, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Novel Oral Anticoagulants (NOACs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Heparin and Low-molecular- weight Heparin (LMWH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Vitamin K Antagonist
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Anticoagulant Market, By Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Atrial Fibrillation/Myocardial Infarction (Heart Attack)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Deep Vein Thrombosis (DVT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Pulmonary Embolism
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Anticoagulant Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dr. Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aspen Holdings
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Leo Pharma AS
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alexion Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Daiichi Sankyo Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us